Chethana Medicaments Pvt Ltd - Due diligence report

A 360° intelligence report on Chethana Medicaments Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and di…

1994-01-10 Malappuram, Kerala Active Unlisted Active Compliant
Share
View plans
CM Chethana Medicaments Pvt Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Chethana Medicaments Pvt Ltd — 360° Intelligence Report

Generated from MCA filings & public records
82/100
Trust Score
Low Risk

Chethana Medicaments Pvt Ltd is assessed as Low Risk with a Trust Score of 82/100. Chethana Medicaments Pvt Ltd is an active private limited indian non-government company incorporated in 1994, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 04 Jul 2026 from the latest processed filings. Chethana Medicaments Pvt Ltd snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
30/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 30/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 3 open (25.00 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Dhanlaxmi Bank Limited2 48.0 cr
Dhanalakshmi1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
AVANOORMANA DAMODARAN NAMBUDIRI 01234567 Director 01/04/2018 6 yrs Approved
NARAYANAN AVANOOR MANA 01234567 Director 01/04/2018 6 yrs Approved
KUNNAKKAVU PUTHUMANA PURUSHOTHAMAN 01234567 Director 01/04/2018 6 yrs Approved
SARASWATHY VANCHERI NARAYANAN 01234567 Director 01/04/2018 6 yrs Approved
DAMODAR AVANOOR 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a majority stake - exact percentages are part of the full report.

Key managerial personnel: AVANOORMANA DAMODARAN NAMBUDIRI (Whole-time director) · KUNNAKKAVU PUTHUMANA PURUSHOTHAMAN (Managing Director) · DAMODAR AVANOOR (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 75
Growth signals & trust indicators
Operating for 32+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
3 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment54/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 25.00 Lakh already registered.
  • Compliance record supports lending.
Investor view54/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
27 Jul 2020
Charge created
Dhanlaxmi Bank Limited - 3.50 Lakh
30 Sep 2019
Director ceased
SARASWATHY VANCHERI NARAYANAN
17 Jun 2019
Director appointed
SARASWATHY VANCHERI NARAYANAN (Director)
24 Sep 2018
Charge created
Dhanlaxmi Bank Limited - 20.00 Lakh
20 Sep 2018
Director ceased
VANCHERI NAMBOOTHIRI NARAYANAN NAMBOOTHIRI
11 Nov 1995
Charge created
Dhanalakshmi - 1.50 Lakh
01 Nov 1995
Director appointed
NARAYANAN AVANOOR MANA (Director)
10 Jan 1994
Incorporated
Registered with Roc Ernakulam
Director appointed
AVANOORMANA DAMODARAN NAMBUDIRI (Whole-time director)
Director appointed
KUNNAKKAVU PUTHUMANA PURUSHOTHAMAN (Managing Director)
Director appointed
DAMODAR AVANOOR (Whole-time director)
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a majority stake as per the FY 2021 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
K F Agro Private Limited U01132PB1998PTC021937 Punjab, Punjab, India
Goswain Herbs Private Limited U74999WB2016PTC215622 Kolkata, West Bengal, India
Dolphinrfid U74990MH2008PTC178317 Mumbai, Maharashtra, India
Organica Pure Farm Products Private Limited U15494DL2009PTC193930 Delhi, Delhi, India
Tawang Scientific Private Limited U29309WB2019PTC235476 Kolkata, West Bengal, India
Controlp Techno Solutions Private Limited U72900TG2017PTC117734 Secunderabad, Telangana, India
Yaadhadri Trading Private Limited U51900TG2015PTC100821 Hyderabad, Telangana, India
Stanofic Private Limited U52399KA2016PTC092333 Bengaluru, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Chethana Medicaments Pvt Ltd before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Chethana Medicaments Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 30/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Chethana Medicaments Pvt Ltd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Chethana Medicaments Pvt Ltd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Chethana Medicaments Pvt Ltd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Chethana Medicaments Pvt Ltd an active company?

Chethana Medicaments Pvt Ltd has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Chethana Medicaments Pvt Ltd financially healthy?

Chethana Medicaments Pvt Ltd has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Chethana Medicaments Pvt Ltd?

Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Chethana Medicaments Pvt Ltd?

Promoters hold a majority stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Chethana Medicaments Pvt Ltd have loans or charges against its assets?

3 open charge(s) are registered against its assets.

Is Chethana Medicaments Pvt Ltd up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Chethana Medicaments Pvt Ltd?

Its Credit Risk Score is 30/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.